PEG-Intron, a longer-acting form of Intron-A for treating chronic hepatitis C
Schering is now introducing PEG-Intron, a longer-acting form of Intron-A for treating chronic hepatitis C.
PEG-Intron is the first "pegylated" interferon.
It's made by linking polyethylene glycol (PEG) to Intron-A (interferon alfa-2b). PEG slows the metabolism of the interferon to make it longer-acting.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote